Clostridium butyricum inhibits the progression of colorectal cancer and alleviates intestinal inflammation via the myeloid differentiation factor 88 (MyD88)-nuclear factor-kappa B (NF-κB) signaling pathway
Author(s) -
Mingyao Zhou,
Wei Yuan,
Bing Yang,
Wei Pei,
Jie Ma,
Qiang Feng
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-1670
Subject(s) - azoxymethane , clostridium butyricum , tunel assay , microbiology and biotechnology , terminal deoxynucleotidyl transferase , apoptosis , chemistry , cancer research , biology , colorectal cancer , cancer , medicine , biochemistry , fermentation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom